Research & Development



  衛青莞爾一笑,轉過身對劉據道︰“你理解錯這個打字了,打並非只有軍事手段。   “毒死?”阿嬌吃了一驚,她是真的害怕,雲氏的實驗室里從來不缺少各種毒物。97影院2   潘五笑道︰“殿下想要宇內獨尊,那就要等到登基之後才成,到了那個時候,就沒人能左右殿下了。”色天使   “雲氏教出來的弟子都是妖怪。”   “您就打算一個人撐著?”午夜福利视频合集1000   彭琪笑道︰“不論是趙公,還是王公,他們把活干的太粗,招來了很多詬病,如果微臣進了中尉府,廷尉府,保證把活干的非常漂亮,讓陛下無後顧之憂。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo